MENU
XRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
XORTX Therapeutics (XRTX) Ownership - Who owns XORTX Therapeutics?
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection... Show more
Profile
Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 607-2621
Employees
12
Web
https://www.xortx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.19M
P/E Ratio
8.00
Total Cash
2.3M
Projected Growth
N/A
Total Debt
61.47K
Revenue
N/A
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
XRTX
Capitalization
3.19M
P/E Ratio
8.00
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash
2.3M
Total Cash/Share
0.61
Total Debt
61.5K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.13M
P/B Ratio
0.98
Cash Flow
N/A
Earnings
0.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.9M
Current Ratio
1.40
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-4.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.04
Shares Held By Institutions
323K
Shares Outstanding - Current
3.79M
Total Liabilities
1.72M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-23.778
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 607-2621
Employees
12
Web
https://www.xortx.com